These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Efficacy of microwave coagulation therapy (MCT) in patients with liver tumors]. Beppu T; Ogawa M; Matsuda T; Ohara C; Hirota M; Shimada S; Yamaguchi Y; Yamanaka T Gan To Kagaku Ryoho; 1998 Jul; 25(9):1358-61. PubMed ID: 9703828 [TBL] [Abstract][Full Text] [Related]
45. [NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis]. Qin J Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):209-11, 254. PubMed ID: 2151030 [TBL] [Abstract][Full Text] [Related]
46. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver. Nakajima T; Mizushima N; Kanai K Jpn J Clin Oncol; 1987 Dec; 17(4):327-32. PubMed ID: 2826847 [TBL] [Abstract][Full Text] [Related]
47. Thoracoscopic microwave coagulation therapy for hepatocellular carcinoma. Asahara T; Katayama K; Itamoto T; Okamoto Y; Nakahara H; Yoshioka S; Ono E; Dohi K; Kitamoto M; Nakanishi T; Moriwaki K; Shiroyama K; Yuge O Hiroshima J Med Sci; 1998 Sep; 47(3):125-31. PubMed ID: 9810785 [TBL] [Abstract][Full Text] [Related]
48. [Evaluation of percutaneous microwave hepatic tumor coagulation therapy (PMTC) under general anesthesia from viewpoint of quality of life (QOL)]. Niinobu T; Shibata T; Takami M; Tsujinaka T; Takada T; Kitada M; Tsukahara Y; Murotani M; Iihara K; Tsukamoto F; Ogawa M; Kimura M Gan To Kagaku Ryoho; 1996 Sep; 23(11):1600-2. PubMed ID: 8854816 [TBL] [Abstract][Full Text] [Related]
49. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521 [TBL] [Abstract][Full Text] [Related]
50. [Microwave tissue coagulation therapy with mini-laparotomy for hepatocellular carcinoma]. Masutani S; Tatsuta M; Kawasaki T; Hashimoto K; Morimoto O; Tsuji Y; Baba S; Miya A; Ishida H; Satomi T Gan To Kagaku Ryoho; 1998 Jul; 25(9):1370-3. PubMed ID: 9703831 [TBL] [Abstract][Full Text] [Related]
51. MR-guided microwave thermocoagulation therapy of liver tumors: initial clinical experiences using a 0.5 T open MR system. Morikawa S; Inubushi T; Kurumi Y; Naka S; Sato K; Tani T; Yamamoto I; Fujimura M J Magn Reson Imaging; 2002 Nov; 16(5):576-83. PubMed ID: 12412035 [TBL] [Abstract][Full Text] [Related]
52. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439 [TBL] [Abstract][Full Text] [Related]
53. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634 [TBL] [Abstract][Full Text] [Related]
54. [Analysis of serum T-lymphocyte subsets and NK cell activity in patients with hypopharyngeal squamous cell carcinoma]. Chen WK; Song M; Chen FJ; Guo ZM; He LR; Yan SL Ai Zheng; 2006 Oct; 25(10):1300-2. PubMed ID: 17059781 [TBL] [Abstract][Full Text] [Related]
55. [NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use]. Yamamoto S; Takatori K; Ohmoto K; Ideguchi S; Yamamoto R; Ohumi T; Hino K; Hirano Y Gan To Kagaku Ryoho; 1989 Sep; 16(9):3291-4. PubMed ID: 2551254 [No Abstract] [Full Text] [Related]
56. Percutaneous microwave coagulation therapy using artificial ascites. Ohmoto K; Yamamoto S AJR Am J Roentgenol; 2001 Mar; 176(3):817-8. PubMed ID: 11222239 [No Abstract] [Full Text] [Related]
57. [Microwave surgery in the treatment of hepatic cancer]. Zhou XD Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):153-5. PubMed ID: 8223025 [TBL] [Abstract][Full Text] [Related]
58. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma. Lu W; Li YH; He XF; Chen Y; Zeng QL; Qiu YR Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):524-6. PubMed ID: 12297475 [TBL] [Abstract][Full Text] [Related]
59. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Taketomi A; Shimada M; Shirabe K; Kajiyama K; Gion T; Sugimachi K Cancer; 1998 Jul; 83(1):58-63. PubMed ID: 9655293 [TBL] [Abstract][Full Text] [Related]
60. Can hepatocellular carcinoma be cured by microwave coagulation? Scudamore CH HPB Surg; 1998; 11(1):63-4. PubMed ID: 9830585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]